Craig A. Collard - 10 Jun 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Craig Collard
Issuer symbol
N/A
Transactions as of
10 Jun 2022
Net transactions value
+$63,266
Form type
4
Filing time
13 Jun 2022, 16:55:35 UTC
Previous filing
17 May 2022
Next filing
14 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $19,118 +1,663 +3.5% $11.50 49,785 10 Jun 2022 Direct F1
transaction OPNT Common Stock Purchase $44,149 +4,037 +8.1% $10.94 53,822 13 Jun 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $11.48 to $11.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $10.82 to $10.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.